PACT (Platelet Activity After Clopidogrel Termination)
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Clopidogrel is a medication that is used to decrease the ability of platelets to form blood
clots.
The theory has been proposed that, in patients with coronary artery disease or stroke,
increased platelet function after discontinuation of clopidogrel therapy is associated with
an increased clotting risk. However, this theory has never been rigorously tested.
The goal of this research is to determine whether discontinuation of clopidogrel results in
increased platelet function.